Purple Biotech (PPBT) Short-term Investments (2015 - 2026)

Purple Biotech (PPBT) reported Short-term Investments of $859000.0 for Q1 2026, little changed on a QoQ basis from $857000.0 in Q4 2025.

Purple Biotech (PPBT) has 11 years of Short-term Investments data on file, last reported at $859000.0 in Q1 2026.

  • Quarterly Short-term Investments changed N/A year-over-year to $859000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $859000.0 (changed N/A YoY) and the FY2025 annual result came in at $857000.0, up 211.64% from the prior year.
  • Short-term Investments held at $859000.0 in Q1 2026 per PPBT's latest filing, from $857000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $859000.0 in Q1 2026 and bottomed at $73000.0 in Q4 2023.
  • The 5-year median for Short-term Investments is $431000.0 (2022), against an average of $499000.0.
  • The widest annual swing landed in 2022, when Short-term Investments slumped 98.81%; it then jumped 276.71% in 2024.
  • Tracing PPBT's Short-term Investments over 5 years: stood at $431000.0 in 2022, then tumbled by 83.06% to $73000.0 in 2023, then jumped by 276.71% to $275000.0 in 2024, then soared by 211.64% to $857000.0 in 2025, then gained by 0.23% to $859000.0 in 2026.
  • Per Business Quant, the three latest PPBT Short-term Investments figures stand at $859000.0 (Q1 2026), $857000.0 (Q4 2025), and $275000.0 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Purple Biotech 3.58 Bn 3.57 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 859,000.00
Dec 31, 2025 857,000.00
Sep 30, 2025 862,000.00
Jun 30, 2025 857,000.00
Mar 31, 2025 846,000.00
Dec 31, 2024 275,000.00
Sep 30, 2024 848,000.00
Jun 30, 2024 845,000.00
Mar 31, 2024 848,000.00
Dec 31, 2023 850,000.00
Sep 30, 2023 842,000.00
Jun 30, 2023 846,000.00
Mar 31, 2023 849,000.00
Dec 31, 2022 431,000.00
Sep 30, 2022 22.01 Mn
Jun 30, 2022 22.01 Mn
Mar 31, 2022 16.01 Mn
Dec 31, 2021 36.31 Mn
Sep 30, 2021 36.45 Mn
Jun 30, 2021 37.85 Mn
Mar 31, 2021 45.26 Mn
Dec 31, 2020 46.56 Mn
Jun 30, 2020 10,000.00
Dec 31, 2019 2.00 Mn
Jun 30, 2019 5.06 Mn
Dec 31, 2018 1.52 Mn
Jun 30, 2018 6.47 Mn
Dec 31, 2017 3.49 Mn
Jun 30, 2017 7.61 Mn
Dec 31, 2016 7.90 Mn
Jun 30, 2016 4.50 Mn
Dec 31, 2015 141,000.00